KanitakisJCozzaniELyonnetSThivoletJ. Ultrastructural study of chronic lesions of erythema elevatum diutinum: “Extracellular cholesterosis” is a misnomer. J Am Acad Dermatol. 1993;29(2):363-367. doi:10.1016/0190-9622(93)70197-2
2.
CrichlowSMAlexandroffABSimpsonRCSaldanhaGWalkerSHarmanKE. Is IgA antineutrophil cytoplasmic antibody a marker for patients with erythema elevatum diutinum? A further three cases demonstrating this association. Br J Dermatol. 2011;164(3):675-677. doi:10.1111/J.1365-2133.2010.10172.X
3.
DoktorVHadiAHadiAPhelpsRGoodheartH. Erythema elevatum diutinum: a case report and review of literature. Int J Dermatol. 2019;58(4):408-415. doi:10.1111/IJD.14169
4.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/BMJ.N71
5.
MuradMHSultanSHaffarSBazerbachiF. EBM implementation: methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60. doi:10.1136/BMJEBM-2017-110853
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
